RxDoctor Payments Data

Jonathon Ngo, PA

Medical · Frisco, TXNPI 1003568452

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Johnson & Johnson at 31.5% of the total. Reporting peaked in 2024 at $172 and has fallen 54.5% since, to $78 in 2025. That places this record below the midpoint for medical clinicians in TX, where the typical reported total is $657.

$360in general payments, 2019–2025

Across 13 payments — averaging $27.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$114
  • Bioventus LLC$58
  • Pylant Medical$55
  • Smith+Nephew$52
  • Medtronic$33
  • Dynasplint Systems Inc.$25
  • plus $24 from 1 others

What the payments were for

  • Food & beverage$360100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)5$114
Bioventus LLC2$58
Pylant Medical1$55
Smith+Nephew2$52
Medtronic1$33
Dynasplint Systems Inc.1$25
Fidia Pharma USA Inc.1$24

How this compares

$360 in reported general payments places this provider in the 40th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas →

Medicare billing

Part B allowed, 2024
$50,655
Medicare patients
188
Services billed
2,679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin101$154
Minocycline Hcl11$45
Clindamycin Hcl12$15

Paid to pharmacies, not to this prescriber.

Other medical in Frisco

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →